<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01289418</url>
  </required_header>
  <id_info>
    <org_study_id>pcirn-surveillancehcw-0910</org_study_id>
    <nct_id>NCT01289418</nct_id>
  </id_info>
  <brief_title>Surveillance for Adverse Events Following Pandemic H1N1 Immunization</brief_title>
  <official_title>Short and Long-Term Electronic Surveillance of a Large Number of Healthcare Workers Following Administration of an Adjuvanted Ph1n1 Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>PHAC/CIHR Influenza Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National en Santé Publique du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU de Quebec-Universite Laval</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Elizabeth II Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mount Sinai Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Ottawa Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alberta Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vancouver General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>PHAC/CIHR Influenza Research Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Influenza vaccines are continuously modified to adjust to the virus antigenic shifts or
      drifts, and its safety profile may vary. While generally considered safe, influenza vaccines
      have been associated in the past with increases in cases of Guillain-Barré syndrome (1976) or
      with oculorespiratory syndrome (2001). The emergence of a novel strain of H1N1 influenza
      virus (pH1N1) has prompted health departments worldwide to prepare for mass vaccination
      campaigns with a new H1N1 pandemic vaccine. Following recommendations of the World Health
      Organization (WHO), Canada immunized its population with a dose-sparing adjuvanted vaccine.
      While the adjuvant developed by GlaxoSmithKline (GSK) has been administered to over 39 000
      people, only a few hundred will have been vaccinated with the H1N1 formulation in clinical
      trials before the mass campaign was launched. With this small number, adverse events
      occurring at a rate &lt; 1% will not be detected by these clinical trials.

      Considering that most cases of pH1N1 to date have been relatively mild, it will be imperative
      to rapidly detect adverse events serious enough to reconsider the use of the vaccine. Passive
      surveillance is collecting notifications of adverse events but the sensitivity of this system
      is not high and its timeliness is not necessarily optimal.

      In Canada, healthcare workers (HCW) are among those who were offered the new pandemic vaccine
      in priority. Because they were offered the vaccine early in the campaign and because they
      constitute a well-defined group in good general health, this group of people may be well
      suited for monitoring the safety of the pH1N1 vaccine.

      The main objective of this project was to estimate in HCW vaccinated against pH1N1 the
      frequency of adverse events of sufficient severity to cause work absenteeism or medical
      consultation.

      The active surveillance was done in HCW from 3 sites (Canadian hospitals) participating in
      the Pandemic Influenza Research Network (PCIRN): (1) Halifax (Nova Scotia), (2) Quebec City
      (Quebec): 3 hospitals, (3) Toronto
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation.</measure>
    <time_frame>at day 8, 15 and 29</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.</measure>
    <time_frame>day 8, 15 and 29</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>the Occurrence of Serious Adverse Events (SAE)</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">6525</enrollment>
  <condition>Novel Influenza A/H1N1</condition>
  <arm_group>
    <arm_group_label>Health care workers in Québec</arm_group_label>
    <description>Health care workers from CHUQ hospitals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health care workers in Toronto</arm_group_label>
    <description>Health care workers from the Mount Sinai Hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health care workers in Halifax</arm_group_label>
    <description>Health care workers from the Queen Elizabeth Hospital</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The active surveillance was conducted in three Canadian hospitals participating in the
        Public Health Agency of Canada/Canadian Institutes for Health Research- Influenza Research
        Network (PCIRN): Quebec City, Toronto, and Halifax. Healthcare workers immunized in these
        institutions were offered to participate in a web-based active surveillance of vaccine
        safety.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To be a health care worker from one of the three Canadian Hospitals participating in
             the Public Health Agency of Canada/Canadian Institutes for Health Research- Influenza
             Research Network (PCIRN): Quebec City, Toronto, and Halifax.

          -  To have been immunized with the pH1N1 vaccine.

          -  To have an email address.

          -  To be 18 years old and older.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaston De Serres, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National en Santé Publique du Québec</affiliation>
  </overall_official>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2011</study_first_submitted>
  <study_first_submitted_qc>February 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2011</study_first_posted>
  <results_first_submitted>July 9, 2012</results_first_submitted>
  <results_first_submitted_qc>July 9, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 14, 2012</results_first_posted>
  <last_update_submitted>August 15, 2012</last_update_submitted>
  <last_update_submitted_qc>August 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Gaston De Serres</investigator_full_name>
    <investigator_title>Epidemiologist at the National Institute of Public Health of Quebec and professor of epidemiology at the University Laval</investigator_title>
  </responsible_party>
  <keyword>H1N1</keyword>
  <keyword>vaccine safety</keyword>
  <keyword>adverse events</keyword>
  <keyword>health care workers</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Health Care Workers</title>
          <description>Health care workers from all hospitals</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Day 8 Survey</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6525"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4307"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2218"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>email address invalid</title>
              <participants_list>
                <participants group_id="P1" count="283"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>participants did not complete the survey</title>
              <participants_list>
                <participants group_id="P1" count="1935"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Day 29 Survey</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6525"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4057"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2468"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>email address invalid</title>
              <participants_list>
                <participants group_id="P1" count="283"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>participants did not complete the survey</title>
              <participants_list>
                <participants group_id="P1" count="2185"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Health Care Workers in Quebec</title>
          <description>Health care workers from Quebec</description>
        </group>
        <group group_id="B2">
          <title>Health Care Workers in Toronto</title>
          <description>Health Care Workers from Toronto</description>
        </group>
        <group group_id="B3">
          <title>Health Care Workers in Halifax</title>
          <description>Health Care Workers from Halifax</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5183"/>
            <count group_id="B2" value="519"/>
            <count group_id="B3" value="823"/>
            <count group_id="B4" value="6525"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B3" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3152"/>
                    <measurement group_id="B2" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B3" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B4" value="3152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B3" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.5" spread="11.7"/>
                    <measurement group_id="B2" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B3" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B4" value="37.5" spread="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>Demographic data was collected in only one site (n=3159). Some participants did not complete all the questions. That's why we don't have the age and the gender for all the participants.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2310"/>
                    <measurement group_id="B2" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B3" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B4" value="2310"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="841"/>
                    <measurement group_id="B2" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B3" value="NA">demographic data were available only for Quebec</measurement>
                    <measurement group_id="B4" value="841"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5183"/>
                    <measurement group_id="B2" value="519"/>
                    <measurement group_id="B3" value="823"/>
                    <measurement group_id="B4" value="6525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation.</title>
        <time_frame>at day 8, 15 and 29</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Health Care Workers</title>
            <description>Health care workers with a valid e-mail address</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation.</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="234"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.</title>
        <time_frame>day 8, 15 and 29</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Health Care Workers</title>
            <description>Health care workers with a valid email address</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6242"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="374"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>the Occurrence of Serious Adverse Events (SAE)</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Health Care Workers From CHUQ Hospitals</title>
          </group>
        </group_list>
        <measure>
          <title>the Occurrence of Serious Adverse Events (SAE)</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3064"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Health Care Workers From CHUQ Hospitals</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>pancreas cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Eye problem</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>abdominal problems</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>severe headaches</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Respiratory infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>cutaneous infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>toxic shock syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>no diagnosis</sub_title>
                <description>intermittent pain in the arm.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal problems</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>gynecologic problems/obstetrical</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>cervix precancerous cells</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>gynecologic problems</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>ear surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
              <event>
                <sub_title>Vaso-vasectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3064"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="383" subjects_at_risk="4984"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>gastroenteritis</sub_title>
                <counts group_id="E1" events="73" subjects_affected="73" subjects_at_risk="4984"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>myalgia</sub_title>
                <counts group_id="E1" events="70" subjects_affected="70" subjects_at_risk="4984"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>respiratory problems</sub_title>
                <counts group_id="E1" events="201" subjects_affected="201" subjects_at_risk="4984"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Local reaction</sub_title>
                <counts group_id="E1" events="39" subjects_affected="39" subjects_at_risk="4984"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Only 52% answered the 3 surveys. We don't know why 48% didn't complete the 3 surveys (were they too sick or not motivated).We didn't have a group of comparable unvaccinated individuals (to estimate the risks attributable to the vaccine).</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Gaston De Serres</name_or_title>
      <organization>Laval University</organization>
      <phone>418-666-7000 ext 274</phone>
      <email>gaston.deserres@ssss.gouv.qc.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

